Beriberi epidemiology and demographics

Jump to navigation Jump to search

Beriberi Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Beriberi from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Beriberi epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Beriberi epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Beriberi epidemiology and demographics

CDC on Beriberi epidemiology and demographics

Beriberi epidemiology and demographics in the news

Blogs on Beriberi epidemiology and demographics

Directions to Hospitals Treating Beriberi

Risk calculators and risk factors for Beriberi epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Epidemiology and Demographics

Incidence

  • No clear data are available on the incidence rate of beriberi.

Prevalence

  • Due to the absence of clear data on beriberi prevalence in children, the World Health Organization suggested that infant mortality curves can reflect thiamine deficiency in infants.[1]
  • The main reason an exact prevalence rate cannot be identified is that different studies used different blood thiamine concentration cutoffs.[2]

Age

  • The infantile form of beriberi occurs in infants under one year of age: Cardiac form (1 to 3 months), aphonic (4 to 6 months), and pseudomeningitic (7 to 9 months).

Race

  • There is no racial predilection to beriberi.

Gender

  • Beriberi affects men and women equally. However, pregnant women may be at risk.

Region

  • The majority of beriberi cases are reported in geographical regions with inadequate dietary intake (developing countries). In developed countries, it may occur in individuals with chronic illness or alcoholism.[3]

References

  1. Luxemburger C, White NJ, ter Kuile F, Singh HM, Allier-Frachon I, Ohn M; et al. (2003). "Beri-beri: the major cause of infant mortality in Karen refugees". Trans R Soc Trop Med Hyg. 97 (2): 251–5. doi:10.1016/s0035-9203(03)90134-9. PMID 14584386.
  2. Whitfield KC, Smith G, Chamnan C, Karakochuk CD, Sophonneary P, Kuong K; et al. (2017). "High prevalence of thiamine (vitamin B1) deficiency in early childhood among a nationally representative sample of Cambodian women of childbearing age and their children". PLoS Negl Trop Dis. 11 (9): e0005814. doi:10.1371/journal.pntd.0005814. PMC 5600402. PMID 28873391.
  3. Whitfield KC, Bourassa MW, Adamolekun B, Bergeron G, Bettendorff L, Brown KH; et al. (2018). "Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs". Ann N Y Acad Sci. 1430 (1): 3–43. doi:10.1111/nyas.13919. PMC 6392124. PMID 30151974.


Template:WikiDoc Sources